<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7416109\results\search\drug\results.xml">
  <result pre="till date to evaluate the safety and effectiveness of the" exact="dexamethasone" post="(a corticosteroid) for the management of SARS-CoV-2 infection (https://clinicaltrials.gov/ct2/results?cond=covid-19&amp;amp;term=dexamethasone&amp;amp;cntry=&amp;amp;state=&amp;amp;city=&amp;amp;dist=)."/>
  <result pre="(a corticosteroid) for the management of SARS-CoV-2 infection (https://clinicaltrials.gov/ct2/results?cond=covid-19&amp;amp;term=dexamethasone&amp;amp;cntry=&amp;amp;state=&amp;amp;city=&amp;amp;dist=). Recently," exact="dexamethasone" post="was declared as the world's first treatment proven effective"/>
  <result pre="investigate several potential COVID-19 treatments on hospitalized patients [3]. Moreover," exact="dexamethasone" post="has been proven to significantly reduce the mortality risk"/>
  <result pre="as much as 35% and 20%, respectively. After that, the" exact="dexamethasone" post="has been authorized by the UK government for the"/>
  <result pre="hospitalized COVID-19 patients, not on oxygen or ventilation [4]. The" exact="dexamethasone" post="(synthetic pregnane corticosteroid; a cortisol derivative) is a well-known"/>
  <result pre="oxygen or ventilation [4]. The dexamethasone (synthetic pregnane corticosteroid; a" exact="cortisol" post="derivative) is a well-known lifesaving drug and commonly used"/>
  <result pre="of different anti-inflammatory cytokines [5]. Fig. 1 An overview of" exact="dexamethasone" post="and its mode of action in COVID-19 patients. Additionally,"/>
  <result pre="pneumonia [6]. In this context, the anti-inflammatory effect of the" exact="dexamethasone" post="is suggested to probably counter the cytokine storm caused"/>
  <result pre="launched to test the hypothesis of whether early administration of" exact="dexamethasone" post="along with IV-IG and IFN-Î² can reduce the harmful"/>
  <result pre="cytokine storm in critically ill COVID-19 patients or not. Moreover," exact="dexamethasone" post="is approved by the FDA as a broad-spectrum immunosuppressant"/>
  <result pre="with an added advantage of longer duration of action. Furthermore," exact="dexamethasone" post="is suggested to limit the production of inflammatory cytokines"/>
  <result pre="concern and needs further investigation [6]. The breakthrough discovery of" exact="dexamethasone" post="as the first drug to save lives is very"/>
  <result pre="of the general population [6]. However, finding effective drugs like" exact="dexamethasone" post="will transform the global impact of the COVID-19 pandemic"/>
  <result pre="with 2019 novel coronavirus in Wuhan, ChinaLancet39510223202049750610.1016/S0140-6736(20)3018331986264 3MahaseE.Covid-19: demand for" exact="dexamethasone" post="surges as RECOVERY trial publishes preprintBMJ3692020m251210.1136/bmj.m2512 4LedfordH.Coronavirus breakthrough: dexamethasone"/>
  <result pre="for dexamethasone surges as RECOVERY trial publishes preprintBMJ3692020m251210.1136/bmj.m2512 4LedfordH.Coronavirus breakthrough:" exact="dexamethasone" post="is first drug shown to save livesNature202010.1038/d41586-020-01824-5 5RhenT.CidlowskiJ.A.Anti-inflammatory action"/>
 </snippets>
</snippetsTree>
